Private Management Group Inc Bausch Health Companies Inc. Transaction History

Private Management Group Inc

  • $2.62 Billion
  • Q3 2024

A detailed history of Private Management Group Inc transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Private Management Group Inc holds 1,493,063 shares of BHC stock, worth $11 Million. This represents 0.46% of its overall portfolio holdings.

Number of Shares
1,493,063
Previous 1,495,953 0.19%
Holding current value
$11 Million
Previous $10.4 Million 16.71%
% of portfolio
0.46%
Previous 0.42%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$5.22 - $8.26 $15,085 - $23,871
-2,890 Reduced 0.19%
1,493,063 $12.2 Million
Q2 2024

Aug 06, 2024
BUY
$6.1 - $10.41 $2.74 Million - $4.68 Million
449,623 Added 42.97%
1,495,953 $10.4 Million
Q1 2024

May 08, 2024
SELL
$7.77 - $10.61 $34,390 - $46,959
-4,426 Reduced 0.42%
1,046,330 $11.1 Million
Q4 2023

Feb 01, 2024
SELL
$6.53 - $8.23 $26,675 - $33,619
-4,085 Reduced 0.39%
1,050,756 $8.43 Million
Q3 2023

Oct 30, 2023
SELL
$7.69 - $9.71 $43,056 - $54,366
-5,599 Reduced 0.53%
1,054,841 $8.67 Million
Q2 2023

Aug 07, 2023
SELL
$5.72 - $8.8 $35,366 - $54,410
-6,183 Reduced 0.58%
1,060,440 $8.48 Million
Q1 2023

May 08, 2023
SELL
$6.28 - $9.85 $32,511 - $50,993
-5,177 Reduced 0.48%
1,066,623 $8.64 Million
Q4 2022

Feb 02, 2023
SELL
$6.09 - $7.93 $3.57 Million - $4.65 Million
-586,324 Reduced 35.36%
1,071,800 $6.73 Million
Q3 2022

Feb 06, 2023
BUY
$4.58 - $9.21 $2.69 Million - $5.4 Million
586,324 Added 54.7%
1,658,124 $11.4 Million
Q3 2022

Feb 06, 2023
BUY
$4.58 - $9.21 $2.69 Million - $5.4 Million
586,324 Added 54.7%
1,658,124 $11.4 Million
Q3 2022

Nov 08, 2022
SELL
$4.58 - $9.21 $59,622 - $119,895
-13,018 Reduced 0.78%
1,658,124 $11.4 Million
Q2 2022

Aug 05, 2022
BUY
$7.06 - $23.63 $2.97 Million - $9.94 Million
420,534 Added 33.63%
1,671,142 $14 Million
Q1 2022

May 06, 2022
BUY
$21.6 - $27.79 $299,548 - $385,391
13,868 Added 1.12%
1,250,608 $28.6 Million
Q4 2021

Feb 08, 2022
BUY
$23.0 - $29.01 $1.79 Million - $2.26 Million
78,042 Added 6.74%
1,236,740 $34.1 Million
Q3 2021

Nov 09, 2021
BUY
$25.04 - $30.06 $1.53 Million - $1.83 Million
60,983 Added 5.56%
1,158,698 $32.3 Million
Q2 2021

Jul 23, 2021
BUY
$27.43 - $32.7 $1.25 Million - $1.49 Million
45,717 Added 4.35%
1,097,715 $32.2 Million
Q1 2021

May 11, 2021
SELL
$21.37 - $34.38 $815,030 - $1.31 Million
-38,139 Reduced 3.5%
1,051,998 $33.4 Million
Q4 2020

Feb 03, 2021
SELL
$15.31 - $21.12 $97,126 - $133,985
-6,344 Reduced 0.58%
1,090,137 $22.7 Million
Q3 2020

Nov 12, 2020
SELL
$14.88 - $20.13 $318,342 - $430,661
-21,394 Reduced 1.91%
1,096,481 $17 Million
Q2 2020

Aug 13, 2020
SELL
$13.31 - $20.51 $263,564 - $406,139
-19,802 Reduced 1.74%
1,117,875 $20.4 Million
Q1 2020

May 13, 2020
SELL
$12.98 - $30.25 $222,568 - $518,696
-17,147 Reduced 1.48%
1,137,677 $17.6 Million
Q4 2019

Feb 12, 2020
SELL
$18.89 - $31.89 $1.16 Million - $1.97 Million
-61,669 Reduced 5.07%
1,154,824 $34.6 Million
Q3 2019

Nov 12, 2019
BUY
$20.88 - $25.66 $529,871 - $651,173
25,377 Added 2.13%
1,216,493 $26.6 Million
Q2 2019

Aug 12, 2019
SELL
$20.52 - $26.45 $191,985 - $247,466
-9,356 Reduced 0.78%
1,191,116 $30 Million
Q1 2019

May 10, 2019
SELL
$20.23 - $26.29 $620,980 - $806,997
-30,696 Reduced 2.49%
1,200,472 $29.7 Million
Q4 2018

Feb 06, 2019
BUY
$17.64 - $28.32 $141 - $226
8 Added 0.0%
1,231,168 $22.7 Million
Q3 2018

Nov 13, 2018
BUY
$20.64 - $25.67 $122,663 - $152,556
5,943 Added 0.49%
1,231,160 $31.6 Million
Q2 2018

Aug 10, 2018
BUY
$15.07 - $26.86 $18.5 Million - $32.9 Million
1,225,217 New
1,225,217 $28.5 Million

Others Institutions Holding BHC

# of Institutions
254
Shares Held
253M
Call Options Held
5.53M
Put Options Held
16.5M
View Full List

About Bausch Health Companies Inc.

BHC Quotes by TradingView
  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.67B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Private Management Group Inc Portfolio

Follow Private Management Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Management Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Private Management Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email